tiprankstipranks
Boston Scientific (BSX)
NYSE:BSX
US Market
BSX
Boston Scientific
RESEARCH TOOLSreports
Want to see BSX full AI Analyst Report?

Boston Scientific (BSX) Ratios

4,292 Followers

Boston Scientific Ratios

BSX's free cash flow for Q4 2025 was $0.74. For the 2025 fiscal year, BSX's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.62 1.62 1.08 1.32 1.51
Quick Ratio
 1.08 1.08 0.64 0.82 1.02
Cash Ratio
 0.38 0.38 0.06 0.18 0.24
Solvency Ratio
 0.22 0.15 0.18 0.18 0.12
Operating Cash Flow Ratio
 0.83 0.83 0.54 0.51 0.40
Short-Term Operating Cash Flow Coverage
 11.66 11.66 1.93 4.71 76.30
Net Current Asset Value
$ -10.41B$ -10.41B$ -10.47B$ -9.09B$ -9.14B
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.28 0.27 0.29
Debt-to-Equity Ratio
 0.51 0.51 0.51 0.49 0.53
Debt-to-Capital Ratio
 0.34 0.34 0.34 0.33 0.35
Long-Term Debt-to-Capital Ratio
 0.32 0.32 0.29 0.31 0.34
Financial Leverage Ratio
 1.80 1.80 1.81 1.82 1.85
Debt Service Coverage Ratio
 6.14 4.39 1.62 3.81 4.75
Interest Coverage Ratio
 11.62 11.38 6.81 8.02 3.93
Debt to Market Cap
 0.13 0.08 0.08 0.11 0.13
Interest Debt Per Share
 8.60 8.62 7.84 6.72 6.81
Net Debt to EBITDA
 2.18 2.78 2.73 2.50 3.05
Profitability Margins
Gross Profit Margin
70.41%69.01%61.31%62.02%60.83%
EBIT Margin
19.82%18.60%15.94%15.85%12.66%
EBITDA Margin
23.10%18.60%23.51%24.25%21.61%
Operating Profit Margin
20.12%19.78%15.73%15.32%14.38%
Pretax Profit Margin
18.15%16.86%13.63%13.94%9.00%
Net Profit Margin
17.24%14.38%11.07%11.19%5.50%
Continuous Operations Profit Margin
17.26%14.41%11.02%11.18%5.50%
Net Income Per EBT
94.95%85.26%81.24%80.25%61.17%
EBT Per EBIT
90.23%85.24%86.60%91.01%62.55%
Return on Assets (ROA)
8.14%6.61%4.71%4.53%2.15%
Return on Equity (ROE)
15.40%11.91%8.52%8.26%3.97%
Return on Capital Employed (ROCE)
10.85%10.39%7.99%7.22%6.36%
Return on Invested Capital (ROIC)
10.21%8.78%6.13%5.69%3.89%
Return on Tangible Assets
19.34%15.71%11.87%10.80%5.11%
Earnings Yield
4.09%2.04%1.41%1.90%1.05%
Efficiency Ratios
Receivables Turnover
 7.05 6.86 6.55 6.39 6.44
Payables Turnover
 5.33 5.44 6.75 5.74 5.76
Inventory Turnover
 2.07 2.11 2.31 2.18 2.66
Fixed Asset Turnover
 4.58 4.46 4.47 4.32 4.48
Asset Turnover
 0.47 0.46 0.43 0.41 0.39
Working Capital Turnover Ratio
 6.80 10.36 15.93 8.05 6.34
Cash Conversion Cycle
 159.55 158.81 159.96 161.16 130.54
Days of Sales Outstanding
 51.81 53.20 55.75 57.11 56.70
Days of Inventory Outstanding
 176.22 172.73 158.28 167.62 137.17
Days of Payables Outstanding
 68.47 67.12 54.07 63.57 63.33
Operating Cycle
 228.02 225.93 214.03 224.73 193.87
Cash Flow Ratios
Operating Cash Flow Per Share
 3.05 3.06 2.33 1.72 1.07
Free Cash Flow Per Share
 2.44 2.47 1.80 1.17 0.64
CapEx Per Share
 0.61 0.59 0.54 0.55 0.43
Free Cash Flow to Operating Cash Flow
 0.80 0.81 0.77 0.68 0.60
Dividend Paid and CapEx Coverage Ratio
 4.99 5.18 4.35 3.02 2.29
Capital Expenditure Coverage Ratio
 4.99 5.18 4.35 3.13 2.49
Operating Cash Flow Coverage Ratio
 0.37 0.37 0.31 0.26 0.16
Operating Cash Flow to Sales Ratio
 0.22 0.23 0.21 0.18 0.12
Free Cash Flow Yield
4.17%2.59%2.01%2.03%1.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 25.94 48.91 70.89 52.73 94.83
Price-to-Sales (P/S) Ratio
 4.47 7.03 7.85 5.90 5.22
Price-to-Book (P/B) Ratio
 3.80 5.82 6.04 4.36 3.77
Price-to-Free Cash Flow (P/FCF) Ratio
 25.45 38.59 49.69 49.32 72.42
Price-to-Operating Cash Flow Ratio
 20.33 31.13 38.26 33.56 43.37
Price-to-Earnings Growth (PEG) Ratio
 0.35 0.88 4.27 0.37 -2.69
Price-to-Fair Value
 3.80 5.82 6.04 4.36 3.77
Enterprise Value Multiple
 21.55 40.59 36.10 26.82 27.20
Enterprise Value
 97.25B 151.53B 142.17B 92.62B 74.54B
EV to EBITDA
 20.42 40.59 36.10 26.82 27.20
EV to Sales
 4.72 7.55 8.49 6.50 5.88
EV to Free Cash Flow
 26.83 41.42 53.75 54.39 81.56
EV to Operating Cash Flow
 21.45 33.42 41.39 37.01 48.85
Tangible Book Value Per Share
 -0.56 -0.56 -1.20 -0.59 -0.87
Shareholders’ Equity Per Share
 16.32 16.37 14.79 13.27 12.29
Tax and Other Ratios
Effective Tax Rate
 0.05 0.15 0.19 0.20 0.39
Revenue Per Share
 13.88 13.56 11.38 9.80 8.87
Net Income Per Share
 2.39 1.95 1.26 1.10 0.49
Tax Burden
 0.95 0.85 0.81 0.80 0.61
Interest Burden
 0.92 0.91 0.86 0.88 0.71
Research & Development to Revenue
 0.10 0.10 0.10 0.10 0.10
SG&A to Revenue
 0.34 0.34 0.36 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.01 0.02 0.02 0.02
Income Quality
 1.57 1.57 1.86 1.57 2.19
Currency in USD